Sign Out
CRESEMBA is indicated in adults for the treatment of invasive aspergillosis; mucormycosis in patients for whom amphotericin B is inappropriate (see Precautions & Pharmacology: Pharmacodynamics under Actions).
Consideration should be given to official guidance on the appropriate use of antifungal agents.
